AstraZeneca’s Profit Boosted by Its Blockbuster Cancer Drugs

AstraZeneca Plc profit rose more than expected in the third quarter, driven by its booming oncology business.

By Ashleigh Furlong · Bloomberg

AstraZeneca Plc profit rose more than expected in the third quarter, driven by its booming oncology business.